A pharmacokinetic method for designing prolonged-release formulations--propoxyphene hydrochloride.

Suppr

超能文献

作者信息

Rodda B E, Chernish S M, Nash J F

出版信息

J Pharmacokinet Biopharm. 1976 Jun;4(3):243-53. doi: 10.1007/BF01063616.

DOI:10.1007/BF01063616

PMID:978391

Abstract

摘要

相似文献

A pharmacokinetic method for designing prolonged-release formulations--propoxyphene hydrochloride.

J Pharmacokinet Biopharm. 1976 Jun;4(3):243-53. doi: 10.1007/BF01063616.

Propoxyphene and norpropoxyphene: influence of type of controlled-release formulation on intra- and intersubject variations.丙氧芬和去甲丙氧芬：控释制剂类型对个体内和个体间差异的影响。

J Pharm Sci. 1980 Nov;69(11):1327-30. doi: 10.1002/jps.2600691123.

Mathematical model for in vitro drug release from controlled release dosage forms applied to propoxyphene hydrochloride pellets.应用于盐酸丙氧芬微丸的控释剂型体外药物释放的数学模型。

J Pharm Sci. 1982 Jun;71(6):694-9. doi: 10.1002/jps.2600710622.

Plasma concentrations of propoxyphene in man. II. Pharmacokinetics.人体内丙氧芬的血浆浓度。II. 药代动力学。

Int Z Klin Pharmakol Ther Toxikol. 1972 Feb;5(4):381-8.

Influence of first-pass effect on the systemic availability of propoxyphene.

J Clin Pharmacol New Drugs. 1972 Nov-Dec;12(11):449-52. doi: 10.1002/j.1552-4604.1972.tb00245.x.

In vitro evaluation of two controlled release propoxyphene hydrochloride formulations. Influence of the composition of dissolution media on drug release.两种盐酸丙氧芬控释制剂的体外评价。溶出介质组成对药物释放的影响。

Pharm Acta Helv. 1980;55(11-12):312-5.

Generic propoxyphene: need for clinical bioavailability evaluation.普通丙氧芬：临床生物利用度评估的必要性。

J Pharm Sci. 1977 Dec;66(12):1713-6. doi: 10.1002/jps.2600661214.

In vitro and in vivo investigations of a new timed-release dosage form of propoxyphene hydrochloride.盐酸丙氧芬新型缓释剂型的体外和体内研究。

Dan Tidsskr Farm. 1969;43(6):117-26.

Pharmacokinetic interaction of propoxyphene with ethanol.丙氧芬与乙醇的药代动力学相互作用。

Br J Clin Pharmacol. 1985 Mar;19(3):398-401. doi: 10.1111/j.1365-2125.1985.tb02660.x.

D-Propoxyphene: accumulation or altered kinetics?右旋丙氧芬：蓄积还是动力学改变？

Eur J Clin Pharmacol. 1985;28(6):725-6. doi: 10.1007/BF00607926.

引用本文的文献

Gastric emptying of enteric-coated tablets.肠溶片的胃排空

Dig Dis Sci. 1984 Mar;29(3):207-12. doi: 10.1007/BF01296253.

本文引用的文献

Per cent absorbed time plots derived from blood level and/or urinary excretion data.根据血药浓度和/或尿排泄数据得出的吸收百分比-时间曲线图。

J Pharm Sci. 1963 Jun;52:610-1. doi: 10.1002/jps.2600520629.

Theoretical formulation of sustained-release dosage forms.缓释剂型的理论阐述。

J Pharm Sci. 1966 Nov;55(11):1254-63. doi: 10.1002/jps.2600551118.

Determination of propoxyphene in human plasma by gas chromatography.气相色谱法测定人血浆中的丙氧芬。

Anal Chem. 1968 Jul;40(8):1243-6. doi: 10.1021/ac60264a029.

Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment.将人体视为具有单室性质进行药代动力学分析时存在的缺点。

J Pharm Sci. 1968 Jan;57(1):117-23. doi: 10.1002/jps.2600570123.

Sustained release preparations: estimation of plasma concentration in the one compartment open model when release is both immediate and zero order.缓释制剂：在一室开放模型中，当释放同时为即刻释放和零级释放时血浆浓度的估算。

Arch Int Pharmacodyn Ther. 1971 Dec;194(2):290-6.

Plasma concentrations of propoxyphene in man. II. Pharmacokinetics.人体内丙氧芬的血浆浓度。II. 药代动力学。

Int Z Klin Pharmakol Ther Toxikol. 1972 Feb;5(4):381-8.

Plasma concentrations of propoxyphene in man. I. Following oral administration of the drug in solution and capsule forms.人体内丙氧芬的血浆浓度。I. 口服溶液剂和胶囊剂后的情况。

Int Z Klin Pharmakol Ther Toxikol. 1972 Feb;5(4):371-80.

Determination of propoxyphene and norpropoxyphene by chemical ionization mass fragmentography.

Clin Pharmacol Ther. 1975 Jan;17(1):15-20. doi: 10.1002/cpt197517115.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验